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lated under pressure and tension, were found in impinged tis- 
sues. Transcripts encoding collagen I and II were detected by in 
situ hybridisation in hyaline cartilage. Transcript levels and distri- 
bution differed between the impinged tissue and the healthy car- 
tilage, Collagen II was upregulated as it is the case in early stages 
of osteoarthritis. 
Conclusions: The data suggest that the impinged tissue at the 
joint periphery shows characteristics of degeneration similar to
those seen in osteoarthritic artilage. Therefore, impingement 
appears to cause local degenerative changes consistent with 
early osteoarthritis. It remains to be determined if these local 
lesions will lead to a generalized osteoarthritis of the hip. 
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Aim: To Validate an electronic version of the WOMAC QA Index 
version 3.1 .LK for EDC use. 
Method: The Western Ontario and McMaster Universities 
(WOMAC) Osteoarthritis Index records with 24 questions the 
three dimensions for pain (5 questions), stiffness (2 questions) 
and function (17 questions) in patients suffering from hip or knee 
osteoarthritis (OA). This index is globally used in clinical OA trials. 
Electronic data capturing (EDC) is starting to be validated in clin- 
ical trials. 
At 10 study sites, 100 patients were included in a phase IV trial 
with rofecoxib, with radiographically proven OA completed the 
paper and computerized format over an interval of 15 minutes. 
The patients treated for 3 weeks with OA flares had to complete 
the paper and the electronic WOMAC questionnaire 3 times at 
each visit (visit 0/1/3).  The results of the computer- and paper- 
format were compared by intraclass correlation and Spearman's 
correlation coefficient. 
Results: The intraclass correlation coefficients for pain, stiffness 
and function values were 0.915, 0.745 and 0.940 respectively. 
The Spearman correlation coefficients for pain, stiffness and 
function were 0.88, 0.77 and 0.87 respectively. 
Conclusion: These data indicate that the computerized version 
of the WOMAC OA index 3.1 LK could be a valid and feasible 
instrument for EDC outcome measurement in osteoarthritis clini- 
cal trials and daily clinical routine. 
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THE ASSOCIATION OF BODY COMPOSITION 
WITH INCIDENT OSTEOARTHRITIS (OA) 
OF THE KNEE: DATA FROM THE BALTIMORE 
LONGITUDINAL STUDY OF AGING (BLSA) 
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Aim: To examine the association of body fatness, body composi- 
tion and body weight,with incident OA of the knee. 
Methods: Secondary analyses were conducted on longitudinal 
dual photon absorptiometry (DPA) data acquired from 156 men 
and 104 women BLSA participants who had no knee OA on bilat- 
eral standing knee radiographs between 1984 and 199t. Incident 
knee OA was defined as KeUgren-Lawrence grade 2 or higher of 
the more severely affected knee on a follow-up radiograph per- 
formed between 1994 and 1996. Body mass index (BMI) was 
assessed by examination, and fat and muscle mass by DPA. 
ANCOVA with mixed-effects modeling was used to analyze the 
data acquired from 593 DPA scans performed on these 260 sub- 
jects a mean of 1.25 ± 2.9 years prior to the second radiograph. 
Results: 
Adjusted means ± SE 
Age (yrs) at time of initial 
radiograph 
Gender 
BMI (kg/cm 2) 
% Fatness ([g]/weight[g] 
x100) 
% Fat ([g]/ muscle [g] 
x 100) 
Incident knee OA No knee OA 
(n=42) (n=218) 
63.2 ± 1.9 54.4 ± 0.9 
21 men 135 men 
21 women 83 women 
27.3 ± 0.3 26.5 ± 0.3 
36.4 ± 0.9 34.5 ± 0.9 
60 .4±1.5  57 .3±1.4  
After adjustment for BMI, age, gender and time, the fat to body 
weight ratio was higher in subjects with incident knee OA than 
subjects without incident knee OA (p=0.04). Incident knee OA 
subjects also had a higher fat to muscle mass ratio than subjects 
without incident knee OA (p=0.04). 
Conclusion: These results show that fatness and higher fat to 
muscle mass ratio are independently associated with the devel- 
opment of incident knee OA. This association appears to be inde- 
pendent of BMI. 
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LOWER EXTREMITY OSTEOARTHRITIS (OA) INCREASES 
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Aim: This study was conducted to estimate the impact of lower 
extremity OA upon transition of mobility function over 36 months, 
and to evaluate the contributions of strength and weight to these 
transitions. 
Methods: Secondary analyses were conducted of longitudinal 
data acquired for the Women's Health and Aging Study II, a 
prospective, population-based study designed to elucidate the 
transition from pre-clinical to clinical disability in community- 
residing older women. In this cohort exclusive of women with 
rheumatoid arthritis and heart disease, 22 women were classified 
as having knee and hip OA, 80 with knee OA, 7 with hip OA, and 
208 with neither knee nor hip OA at baseline using clinical algo- 
rithms modeled on the ACR criteria. Transitions to new clinical 
mobility disability was assessed at the 18 and 36-month follow- 
up by self-report of difficulty with aerobic tasks (walking a half- 
mile or climbing stairs), non-aerobic tasks (bending, stooping or 
transferring into or out of a car or bus), or combined (aerobic and 
non-aerobic task difficulty reported). Baseline demographic har- 
acteristics, strength and weight of women with lower extremity 
OA were compared to those with no lower extremity OA using 
ANOVA, and entered into logistic regression models to determine 
the odds of transitions to additional disability categories over 36 
months. 
Results: Lower extremity OA was associated with a 7.42 greater 
risk (p =0.003) for aerobic mobility tasks, and 2.48 greater risk of 
transition to combined aerobic and non-aerobic task difficulty (p 
= 0.013). Women with lower extremity OA had lower baseline 
weight-adjusted knee extensor strength (0.269 kg/kg weight) and 
higher weight (72.7kg) than no lower extremity OA group (0.298 
kg/kg weight and 65.5kg respectively; p=<0.05). In this sample, 
baseline lower strength (RR=0.02) and higher weight (RR=1.03 
per kg) were independently associated with greater risk of dis- 
ability transitions (p < 0.05). Baseline lower strength was also a 
risk factor for incident knee pain over 36 months (p < 0.01). 
Conclusions: Lower extremity OA, lower knee extensor strength, 
and higher weight increase the risk of disability transitions ub- 
stantially over 36 months in high functioning older women, 
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EVALUATION OF SAFETY AND EFFICACY OF HYLAN GF-20 
IN KNEE OSTEOARTHRITIS WITH CHONDROCALClNOSIS 
Virginie Legre, Thao Pham, Pierre Lafforgue 
Department of Rheumatology. CHU La 73mone. 13005 Marseille, 
France 
Background: Pseudogout attacks following hyaluronan and 
hylan intra-articular injections have been reported, suggesting 
that viscosupplementation should be avoided in calcium 
pyrophosphate dihydrate (CPPD) deposition disease. In a previ- 
ous prospective study, we evaluated sodium hyaluronate 
(Hyalgan) injections in a series of osteoarthritis (OA) of the knee 
with chondrocalcinosis, and found no instance of acute 
pyrophosphate arthritis (Daumen-Legre ta!, Arthritis Rheum 
1999, [abstr] 9: Si 58). Only mild local reactions were recorded 
after 7.3% of the injections. No data is yet available concerning 
hylan injections in CPPD disease. 
Objective: To evaluate the occurrence of adverse events and 
the efficacy of a Hylan GF-20 (Synvisc) course in patients with 
both knee OA and CPPD disease. 
Methods: 24 knees in 21 patients with painful osteoarthritis 
(ACR criteria) and radiological typical chondrocalcinosis, were 
given three intraarticular injections of Hylan GF-20 at 1-week 
intervals, with a definite injection technique, in a 6- months fol- 
low-up prospective open study. The occurrence of adverse 
effects and clinical outcome (pain visual analog scale (VAS), func- 
tional Lequesne index, WOMAC) were evaluated at baseline, final 
injection, week 2 and week 22. 
Results: No acute pyrophosphate arthritis occurred in this 
series. 8 transient knee pain or swelling reactions (severe in one 
case) were recorded after the 72 Hylan injections (11%) in 7 
patients, without discontinuation of the treatment. Significant 
improvement of pain and function (p<0.001) was found at evalua- 
tion of 21 knees (3 patients lost), using a Wilcoxon test. 
Conclusion: Hylan GF-20 injections did not induce pseudogout 
attacks in OA patients with CPPD deposits. Transient non crystal 
induced local reactions occurred in 29% of patients. This tudy 
also suggests the beneficial clinical effects of Hylan in knee 
osteoarthritis with chondrocalcinosis. 
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WHO ARE THE PATIENTS WHO CONSULT 
FOR OSTEOARTHRITIS: RESULT OF A NATIONWIDE 
SURVEY ON 10 000 PATIENTS 
P Hilliquin 1, B Fautrel 2, F-A Allaert 3, S Rozenberg 1, 
P Coste 4, M Rossignol 5 
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Osteoarthritis (OA) is a public health problem in many countries, 
but its clinical burden is not precisely known. This is mainly due 
to its considerable variability and the relative lack of reliable clin- 
ical data in administrative databases. 
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Methods: In 2000, a nation-wide survey of more than 5,000 
physicians, either general practitioners (90.3%) or rheumatolo- 
gists (9.7%), representative of the French medical demography, 
was conducted. Each recruited the first 2 patients consulting for 
hip, knee or hand OA after the onset of the survey. 
Results: Clinical and social information was available for'10412 
OA patients, mean-age 66.2 ±10.2 years, sex ratio (F:M) 1.96. For 
84.5% of them, OA diagnosis was based on both clinical and 
radiographic findings. 88.3% had already consulted their physi- 
cian for an OA problem. 
Joint involved 
OA Duration 
Symptoms 
Hand 
Hip 
Knee 
Polya~icular(< 1 jointinvolved) 
Pain only 
Functional Impairment (FI) only 
Pain and FI 
Pain, FI and swelling 
Mean duration of pain previous month 
Mean number of lares in previous year 
Prosthesis Hip 
prevalence Knee 
7.5% 
13.7% 
31.5% 
47.3% 
9.3±6.8 years 
29.1% 
18.6 % 
39.9% 
8.1% 
15.7±6.6 days 
2.4±0.6 
6.6 % 
3.9 % 
Conclusion: This study provides a nationally representative 
description of patients consulting for CA in France. Almost half of 
people consulting for OA have polyarticular thritis. On average, 
patients suffered from OA 15 days within the 30 days preceding 
the visit, and experience between 2 and 3 flares in the year before 
the survey. OA patients who consult seem to have very sympto- 
matic forms of OA. 
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MANAGEMENT OF OSTEOARTHRITIS (OA) WITH PATIENT- 
ADMINISTERED ASSESSMENT TOOLS AND/OR UNSUPER- 
VISED HOME-BASED EXERCISES PROGRAM. 
A 2x2 FACTORIAL DESIGN CLUSTER RANDOMIZED 
CONTROLLED TRIAL 
P Ravaud, B Giraudeau, I Logeart, JS Larguier, R Treves, L 
Euller-Ziegler, B annwarth, M Dougados 
Departement d'Epidemiologie t de Biostatistique, Hopitat 
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Paris 
Objectives: To evaluate the short term symptomatic efficacy of 
patient-administered assessment tools (-Fools) and home non- 
supervised exercises programs (Exercises) alone or in combina- 
tion in OA patients. 
Methods: 
Design. A 24 weeks open cluster randomized controlled-trial with 
a factorial design. 
Setting. French rheumatotogists (n=867) were assigned to 4 
groups: Tools (n=220), Exercises (n=213), Tools + Exercises 
(n=213), no intervention (n=221). Patients. Each r eumatologist 
had to enroll 4 painful OA patients (knee OA: 3, hip OA: 1). 
Interventions. 1) Tools: weekly diary including the record of pain 
and disabling activities 2) Home-based exercises programs with 
the aid of videotape and booklet, performed daily. Concomitant 
therapy. All patients received rofecoxib (12.5 mg or 25 mg QD). 
Outcome variables. 
Pain (VAS 0-100), WOMAC function subscale (0--t00), patient 
assessment of the quality of care (0-100). 
Results: Overall 2957 patients (2216 knee OA, 741 hip OA) were 
included. After 24 weeks, both pain and function improved (-17 + 
27, -20 ± 29, -15 ± 27, -19 ± 29) and (-11 + 19 -12 + 19, -10 + 
19, -11 ± 20) in the different groups (Tools, Exercises, Tools + 
Exercises and no intervention groups respectively), without sta- 
tistical significant difference between groups. Patient's assess- 
ment of rheumatologist implication to preserve their activity was 
